TriSalus Life Sciences, Inc. Long-Term Debt
TriSalus Life Sciences, Inc. (TLSI) had Long-Term Debt of $33.06 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Excluding Current Maturities $33.06M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $33.08M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $33.05M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $32.76M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $33.06M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $33.08M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $33.05M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $32.76M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $32.27M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $31.70M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $22.08M 10-K · filed 2026-03-05 |
| 2024-09-30 | $21.68M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $21.29M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $0.00 10-K/A · filed 2025-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |